Navigation Links
OncoGenex Pharmaceuticals, Inc. Reports Financial Results for Second Quarter 2011 and Provides Update on Development Activities
Date:8/4/2011

andidate, custirsen. Custirsen is currently in Phase 3 clinical development as a treatment in men with metastatic castrate-resistant prostate cancer. The companies plan to begin Phase 3 development of custirsen in first-line treatment of advanced, unrespectable non-small cell lung cancer. OGX-427 is in Phase 2 clinical development; CSP-9222 and OGX-225 are currently in pre-clinical development.

OncoGenex' Forward Looking StatementsThis press release contains forward-looking statements within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning our anticipated product development activities, such as expected clinical trial initiation and completion dates, patient enrollment targets, proposed amendments to our ongoing clinical trial design and the timing and possibility for approval by the FDA thereof, the timing and costs of our product development activities and the potential benefits of our product candidates. All statements other than statements of historical fact are statements that could be deemed forward-looking statements. These statements are based on management's current expectations and beliefs and are subject to a number of risks, uncertainties and assumptions that could cause actual results to differ materially from those described in the forward-looking statements. Such forward-looking statements are subject to risks and uncertainties, including, among others, the risk of delays in our expected clinical trials and the uncertainties regarding patient enrollment rates, the risk that the FDA does not approve our proposed amendment to the Saturn trial design in a timely fashion or at all, the risk that our product candidates do not obtain the requisite regulatory approvals to commercialize, the risk that new developments in the rapidly evolving prostate cancer therapy landscape require additional changes in our clinical trial design or lim
'/>"/>

SOURCE OncoGenex Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. OncoGenex Announces Data Highlighting OGX-427 at American Association of Cancer Research (AACR) 102nd Annual Meeting 2011
2. OncoGenex Pharmaceuticals to Participate in Panel Discussion on Novel Cancer Treatments at RBC Capital Markets Healthcare Conference
3. Isis Pharmaceuticals to Receive $10 Million From OncoGenex License of OGX-011 to Teva
4. OncoGenex Expands Clinical Development of OGX-427 with a Phase 1 Clinical Trial in Bladder Cancer
5. Keryx Biopharmaceuticals, Inc. to Host Conference Call on Second Quarter 2011 Financial Results
6. Pacira Pharmaceuticals, Inc. Announces Data Presentations at the 38th Annual Meeting & Exposition of the Controlled Release Society
7. Pacira Pharmaceuticals, Inc. Announces Timing for Second Quarter 2011 Financial Results Webcast and Conference Call
8. Visionary Pharmaceuticals, Inc., Announces Initial Seed Round Investments and the Launch of TH17 Autoimmune Disease Research Activities
9. Janssen Pharmaceuticals, Inc. Announces Definitive Agreement to Divest Ortho Dermatologics Division
10. Gamma Pharmaceuticals, Inc. Holds Special Shareholders Meeting
11. Sigma-Tau Pharmaceuticals, Inc. Announces Addition of VP of Finance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2014)... , September 19, 2014 ... Pharma IQ den äußerst erfolgreichen Serialisierungs-Countdown-Kalender aktualisiert, der ... Die interaktive PDF, verfügbar unter pharmaserialisation.com , ... dem sie jeweils in Kraft treten. ... Serialisierung nicht länger um das "ob", sondern darum, ...
(Date:9/19/2014)... -- CytRx Corporation (Nasdaq: CYTR ), a biopharmaceutical ... that David J. Haen , Vice President, Business ... Biotech Industry Conference on Friday, September 26 th at ... at the Millennium Broadway Hotel in New ... archived webcast of the presentation will be available on ...
(Date:9/19/2014)... Sept. 19, 2014  PCI is pleased to ... Biotec is a leading provider of Clinical Trial ... Bridgend, Wales in the ... significantly expands PCI,s presence in the UK/EU to ... adding packaging, storage and distribution capacity, as well ...
Breaking Medicine Technology:Pharma IQ stellt weltweite Serialisierungsfristen in seinen Countdown-Kalender 2014 - 2018 2CytRx to Present at BioCentury's 2014 NewsMakers in the Biotech Industry Conference 2CytRx to Present at BioCentury's 2014 NewsMakers in the Biotech Industry Conference 3PCI Announces Acquisition Of Biotec 2PCI Announces Acquisition Of Biotec 3PCI Announces Acquisition Of Biotec 4PCI Announces Acquisition Of Biotec 5PCI Announces Acquisition Of Biotec 6
(Date:9/21/2014)... (PRWEB) September 21, 2014 Top10BestSEOHosting.com, ... ( http://www.top10bestseohosting.com/go/iPage/ ) and GreenGeeks are the most ... want to buy high quality hosting products. ... good hosting suppliers; we recommend two great hosting ... says, “We believe that iPage and GreenGeeks are ...
(Date:9/20/2014)... Recently, UWDress.com, a professional company of women’s dresses and ... announced evening cocktail dresses . As a matter ... are very popular among worldwide customers. Now, all its ... to 65 percent off). , All UWDress.com’s employees ... outfits for the global clients. The company is famous ...
(Date:9/20/2014)... Vegas, NV (PRWEB) September 21, 2014 ... improvement method developed by fitness expert Michael Wren that ... lose stubborn weight and reverse health conditions like high ... the attention of Shane Michaels, prompting an investigative review. ... loss methods and tips upside down by showing people ...
(Date:9/20/2014)... 2014 David Cooke presented two scientific ... poster looked at the clinical benefits of MPI gated ... diastolic function. In conjunction with colleagues at Emory University, ... normal LVEF by echo (>50%). Each patient had same-day ... SPECT. Emory Toolbox 4.0 was used to ...
(Date:9/20/2014)... Islands of Loreto, Baja, Mexico (PRWEB) September 20, 2014 ... of Loreto today announced the resort did not experience ... fully operational, with all amenities and activities available. , ... September 14, 2014, bringing intense wind, rain and powerful ... Baja Peninsula, Villa del Palmar Islands of Loreto experienced ...
Breaking Medicine News(10 mins):Health News:Leading Review Website Top10BestSEOHosting.com Unveils The Best Hosting Suppliers In September 2Health News:Cheap Evening Cocktail Dresses Recently Introduced At UWDress.com 2Health News:Weight Destroyer: Review Exposes Michael Wren’s Guide to Effective Weight Loss and Improved Health 2Health News:Weight Destroyer: Review Exposes Michael Wren’s Guide to Effective Weight Loss and Improved Health 3Health News:Versatility of Emory Toolbox 4.0 Shown at ASNC in Scientific Posters 2Health News:Versatility of Emory Toolbox 4.0 Shown at ASNC in Scientific Posters 3Health News:Villa del Palmar at the Islands of Loreto Fully Functioning After Hurricane 2Health News:Villa del Palmar at the Islands of Loreto Fully Functioning After Hurricane 3
... The Board of,Directors of Golden Meditech Company ... to announce today that the Company has ... market through the,acquisition of Topshine Hospital Management ... largest private haematologist hospitals with,presence in Beijing ...
... at-home blood pressure checks can help control hypertension without ... study of more than 700 Group Health patients ... American Medical Association . , "To our knowledge, ... use Web-based care and a patient-shared electronic medical record ...
... FRANCISCO, June 24 Stewart M. Kiner has,been ... senior market for Blue,Shield of California. In this ... business planning and overall leadership for,the senior market ... and Medicare Part D Drug Plans. Kiner will ...
... Avoid Medicare Cuts and Caps Moves Forward, ... Association (APTA) today hailed passage of the Medicare,Improvements ... the US House of,Representatives as a significant step ... the US Senate to quickly follow suit., ...
... June 24 Neighbors and friends are gathering,June 28th ... isn,t full of rock,stars. It,s Kathie McClure, her family ... the country,gathering stories and talking to people about America,s ... and attorney who learned about the holes in,our health ...
... to imatinib (Gleevec) in patients with chronic myelogenous leukemia ... of the Journal of the National Cancer Institute ... diagnosed CML patients. However, some patients develop resistance to ... in response to mutations in the BCR-ABL gene. In ...
Cached Medicine News:Health News:Golden Meditech Pioneers into China's Hospital Market 2Health News:Golden Meditech Pioneers into China's Hospital Market 3Health News:Golden Meditech Pioneers into China's Hospital Market 4Health News:New online care for hypertension gets results 2Health News:Blue Shield of California Appoints Industry Veteran as New Vice President and General Manager for Senior Market 2Health News:Physical Therapists Applaud House Passage of Medicare Package 2Health News:Mom and Purple Bus Kick-off VoteHealthcare.org Bandwagon Tour 2Health News:Activation of LYN kinase is associated with imatinib-resistance in CML patients 2
... The Lo-Profile™ tracheostomy tube is cosmetically ... ,Two styles of inner cannula come ... inner cannula and a 15 mm ... hook-up. The semi-reusable inner cannula may ...
Disposable Cannula Cuffless Tracheostomy Tubes...
Tube, tracheostomy, cuffed, size 8.0, SS, spiral reinforced PVC....
... KIMBERLY-CLARK BALLARD Adult ... designed for endotracheal intubated ... Features clear T-Piece, lavage/irrigation ... port. Offers multiple tracheostomy ...
Medicine Products: